Kronox Lab Sciences Limited (NSE:KRONOX)

Kronox Lab Sciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,012	1,002	898.62	955.78	822.47	624.6
Other Revenue	-0	-	-	-	1.33	1.59
Revenue	1,012	1,002	898.62	955.78	823.8	626.19
Revenue Growth (YoY)	5.18%	11.50%	-5.98%	16.02%	31.56%	23.29%
Cost of Revenue	496.42	513.18	462.54	552.62	477	347.08
Gross Profit	515.83	488.76	436.09	403.16	346.8	279.11
Selling, General & Admin	70.05	47.54	62.29	70.27	57.82	54.34
Other Operating Expenses	116.27	105.46	87.16	113.05	87.73	73.21
Operating Expenses	203.71	166.82	162.33	198.28	165.84	147.31
Operating Income	312.12	321.95	273.75	204.88	180.96	131.8
Interest Expense	-0.78	-	-	-0.93	-4.05	-3.82
Interest & Investment Income	17.76	17.76	10.17	4.25	3.2	2.78
Currency Exchange Gain (Loss)	3	3	2.16	9.48	3.17	0.95
Other Non Operating Income (Expenses)	14.36	-	-	-0	0.01	0.23
EBT Excluding Unusual Items	346.46	342.71	286.08	217.68	183.29	131.94
Gain (Loss) on Sale of Assets	-	-	-	0.11	0.26	0.27
Other Unusual Items	-	-	-	2.62	-	-
Pretax Income	346.46	342.71	286.08	220.41	183.55	132.21
Income Tax Expense	86.73	88.04	72.57	56.38	47.28	34.91
Net Income	259.73	254.67	213.51	164.03	136.27	97.3
Net Income to Common	259.73	254.67	213.51	164.03	136.27	97.3
Net Income Growth	3.75%	19.28%	30.16%	20.37%	40.05%	14.14%
Shares Outstanding (Basic)	37	37	37	39	39	40
Shares Outstanding (Diluted)	37	37	37	39	39	40
Shares Change (YoY)	0.66%	-	-4.09%	-0.91%	-3.59%	-0.01%
EPS (Basic)	6.99	6.86	5.75	4.24	3.49	2.40
EPS (Diluted)	6.99	6.86	5.75	4.24	3.49	2.40
EPS Growth	3.07%	19.28%	35.72%	21.49%	45.42%	14.02%
Free Cash Flow	-	275.92	51.45	112.5	52.24	96.64
Free Cash Flow Per Share	-	7.44	1.39	2.91	1.34	2.39
Dividend Per Share	-	0.500	0.500	-	-	-
Gross Margin	50.96%	48.78%	48.53%	42.18%	42.10%	44.57%
Operating Margin	30.83%	32.13%	30.46%	21.44%	21.97%	21.05%
Profit Margin	25.66%	25.42%	23.76%	17.16%	16.54%	15.54%
Free Cash Flow Margin	-	27.54%	5.73%	11.77%	6.34%	15.43%
EBITDA	324.96	334.65	286.27	218.21	191.41	141.72
EBITDA Margin	32.10%	33.40%	31.86%	22.83%	23.23%	22.63%
D&A For EBITDA	12.84	12.7	12.51	13.33	10.45	9.92
EBIT	312.12	321.95	273.75	204.88	180.96	131.8
EBIT Margin	30.83%	32.13%	30.46%	21.44%	21.97%	21.05%
Effective Tax Rate	25.03%	25.69%	25.37%	25.58%	25.76%	26.41%
Revenue as Reported	1,052	1,027	914.4	974.98	833.4	632.36

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.